Core Scientific (NASDAQ:CORZ) Sets New 52-Week Low After Insider Selling

by · The Markets Daily

Core Scientific, Inc. (NASDAQ:CORZ – Get Free Report)’s stock price reached a new 52-week low on Thursday after an insider sold shares in the company. The stock traded as low as $12.91 and last traded at $12.5230, with a volume of 261,869 shares trading hands. The stock had previously closed at $13.51.

Specifically, insider Todd DuChene sold 10,000 shares of Core Scientific stock in a transaction that occurred on Monday, October 12th. The stock was sold at an average price of $15.12, for a total transaction of $151,200.00. Following the completion of the transaction, the insider directly owned 1,159,668 shares in the company, valued at approximately $17,534,180.16. The trade was a 0.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Analysts Set New Price Targets

A number of research firms recently weighed in on CORZ. Weiss Ratings reissued a “sell (d-)” rating on shares of Core Scientific in a report on Friday, July 17th. Wolfe Research reaffirmed a “buy” rating on shares of Core Scientific in a report on Wednesday, July 29th. Needham & Company LLC raised their price target on Core Scientific from $29.00 to $35.00 and gave the company a “buy” rating in a report on Wednesday, July 29th. Freedom Capital raised shares of Core Scientific from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 30th. Finally, Compass Point reiterated a “buy” rating and issued a $36.00 price objective on shares of Core Scientific in a report on Wednesday, July 29th. Two equities research analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Core Scientific has a consensus rating of “Moderate Buy” and an average target price of $31.36.

View Our Latest Stock Analysis on Core Scientific

Core Scientific News Summary

Here are the key news stories impacting Core Scientific this week:

  • Positive Sentiment: Analyst targets imply substantial upside. Canaccord Genuity reaffirmed a “Buy” rating with a $36 price target, while BTIG Research maintained its “Buy” rating and set a $38 target. Cantor Fitzgerald also reaffirmed its “Overweight” rating with a $39 target. These targets reflect analysts’ confidence in Core Scientific’s data-center and artificial-intelligence infrastructure growth prospects. Canaccord Genuity analyst rating
  • Positive Sentiment: Needham maintained a $35 price target. The firm reiterated its bullish outlook despite credit-related concerns involving CoreWeave, Core Scientific’s tenant and key AI infrastructure customer. Needham reiterates Core Scientific target
  • Neutral Sentiment: Third-quarter results are scheduled for November 5. Core Scientific will release fiscal third-quarter 2026 results before market open and host a conference call at 8:30 a.m. Eastern time. The event gives investors a near-term catalyst to assess revenue growth, profitability, data-center expansion and customer concentration. Core Scientific earnings release announcement
  • Negative Sentiment: An insider sold $151,200 of stock. Director Todd Duchene sold 10,000 shares at an average price of $15.12, reducing his direct ownership by 0.85%. Although he still owns more than 1.15 million shares, the transaction may add modest selling pressure or raise caution among investors. Core Scientific insider sale
  • Negative Sentiment: Credit concerns surrounding CoreWeave could weigh on sentiment. Because CoreWeave is an important tenant, questions about its financial strength could increase concerns about customer concentration, contract execution and the pace of Core Scientific’s AI infrastructure expansion.

Core Scientific Price Performance

The stock has a market capitalization of $3.99 billion, a price-to-earnings ratio of -2.80 and a beta of 5.49. The company’s 50-day simple moving average is $17.58 and its 200-day simple moving average is $21.05.

Core Scientific (NASDAQ:CORZ – Get Free Report) last posted its earnings results on Tuesday, July 28th. The company reported ($3.32) EPS for the quarter, missing the consensus estimate of ($0.06) by ($3.26). The firm had revenue of $164.20 million during the quarter, compared to the consensus estimate of $144.83 million. Research analysts expect that Core Scientific, Inc. will post -1.36 earnings per share for the current year.

Institutional Trading of Core Scientific

Several hedge funds have recently added to or reduced their stakes in the company. Handelsbanken Fonder AB grew its holdings in Core Scientific by 0.7% in the 2nd quarter. Handelsbanken Fonder AB now owns 94,500 shares of the company’s stock valued at $2,418,000 after buying an additional 700 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of Core Scientific by 34.5% during the second quarter. GAMMA Investing LLC now owns 3,049 shares of the company’s stock worth $78,000 after buying an additional 782 shares in the last quarter. Parkside Financial Bank & Trust lifted its holdings in shares of Core Scientific by 1,371.3% during the second quarter. Parkside Financial Bank & Trust now owns 1,177 shares of the company’s stock worth $30,000 after buying an additional 1,097 shares in the last quarter. Carronade Capital Management LP boosted its position in shares of Core Scientific by 1.1% in the first quarter. Carronade Capital Management LP now owns 101,103 shares of the company’s stock valued at $1,513,000 after acquiring an additional 1,103 shares during the period. Finally, PNC Financial Services Group Inc. boosted its position in shares of Core Scientific by 41.3% in the first quarter. PNC Financial Services Group Inc. now owns 4,396 shares of the company’s stock valued at $66,000 after acquiring an additional 1,285 shares during the period.

About Core Scientific

(Get Free Report)

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers in the United States. Its business has historically centered on cryptocurrency mining, particularly the processing of transactions on the Bitcoin network, while also providing hosting and infrastructure services to other mining and technology customers.

The company is expanding its data center capabilities to support high-performance computing and artificial intelligence workloads. Its services include data center operations, power and equipment management, hosting, and related infrastructure support for customers that require substantial computing capacity.

Core Scientific was founded in 2017 and became a publicly traded company through a business combination in 2022.

Further Reading